Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Vitamin D receptor is crucial for starting hair growth after birth.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hoxc genes control hair growth through Wnt signaling.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

Ectodermal dysplasia causes various symptoms and early treatment is important for eye, dental, and skin issues.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Stump-tailed macaque best for researching hair loss causes and treatments.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

Arctiin helps protect hair cells from damage and death caused by oxidative stress.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.